Pharmacovigilance and COVID-19 : Medicines

Essential medicines

As of may 2022, over 524 million people worldwide have been diagnosed with COVID-19, according to the WHO dashboard. The pandemic has thus far claimed more than 6.2 million lives. Vaccination was having a substantial impact on case figures and hospitalizations in a number of high-income countries, but limited global access to vaccines means that many populations remain vulnerable.

The COVID-19 pandemic and the proliferation of research as well as misinformation has highlighted the need for trustworthy, accessible, and regularly updated guidance to put emerging findings into context and provide clear recommendations for clinical practice.

Ongoing Living Update of Potential COVID-19 Therapeutics Options: Summary of Evidence. Rapid Review

PAHO COVID-19

 

This document Includes the results of a rapid systematic review of currently available literature. The information included in this review reflects the evidence as of the date of this document. In recognition of the fact that there are numerous ongoing clinical studies, PAHO will regularly update this review and the corresponding recommendations as new evidence becomes available.

WHO therapeutics and COVID-19: living guideline

This guideline contains the most up-to-date WHO recommendations for the use of therapeutics in the treatment of COVID-19. The latest version of this guideline is available in pdf format and via an online platform, and is updated regularly as new evidence emerges.

Terapeuticsandcovid

 

 

 

Download here

More information